[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@JessieChimni Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::2561940434.png) @JessieChimni Jasbinder (Jessie) Chimni (My Opinions only)

Jasbinder (Jessie) Chimni (My Opinions only) posts on X about $crsp, $sana, has been, $fate the most. They currently have XXXXX followers and 1180 posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::2561940434/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2561940434/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXX -XXXX%
- X Months XXXXXXX -XX%
- X Year XXXXXXX +46%

### Mentions: X [#](/creator/twitter::2561940434/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2561940434/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX +2.30%
- X Months XXX +43%
- X Year XXX +66%

### Followers: XXXXX [#](/creator/twitter::2561940434/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2561940434/c:line/m:followers.svg)

- X Week XXXXX +0.08%
- X Month XXXXX no change
- X Months XXXXX +5.40%
- X Year XXXXX +16%

### CreatorRank: undefined [#](/creator/twitter::2561940434/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2561940434/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[cryptocurrencies](/list/cryptocurrencies)  [finance](/list/finance)  [stocks](/list/stocks) 

**Social topic influence**
[$crsp](/topic/$crsp) #23, [$sana](/topic/$sana), [has been](/topic/has-been), [$fate](/topic/$fate), [$caba](/topic/$caba), [$allo](/topic/$allo), [$acet](/topic/$acet), [$vrtx](/topic/$vrtx), [vrtx](/topic/vrtx), [$prme](/topic/$prme)

**Top accounts mentioned or mentioned by**
[@geneinvesting](/creator/undefined) [@ny197247](/creator/undefined) [@biomedicalrx](/creator/undefined) [@crisprsam](/creator/undefined) [@yaireinhorn](/creator/undefined) [@elonmusk](/creator/undefined) [@devineni6](/creator/undefined) [@crisprtalk](/creator/undefined) [@tempocap](/creator/undefined) [@mdurgin1](/creator/undefined) [@piratewaffle](/creator/undefined) [@maddstone1](/creator/undefined) [@monacobiotech](/creator/undefined) [@ceoculley](/creator/undefined) [@tesla](/creator/undefined) [@tohjah7809](/creator/undefined) [@scottsinvesting](/creator/undefined) [@skathire](/creator/undefined) [@mohamed42146618](/creator/undefined) [@freshjiva](/creator/undefined)

**Top assets mentioned**
[CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [Vertex Protocol (VRTX)](/topic/$vrtx) [BEAM (BEAM)](/topic/$beam)
### Top Social Posts
Top posts by engagements in the last XX hours

"This post is in the category of "pure speculation". I wonder if $CRSP have partnered with $SANA for the in-vivo CAR-T program 🤔. Steve stated at TD Cowen that they will not jeopardize SC XXX (T1D) from a capital allocation standpoint and will also not slow down SG293 (in-vivo CAR-T). He has been open to finding a partner or an investor to invest in it; he categorically stated that they will not let it die. This may be the time where the two companies see mutual benefit. Their interests are aligned and it could be a win-win for both. $CRSP definitely has the required capital and this is a"  
[X Link](https://x.com/JessieChimni/status/1989736584607125593)  2025-11-15T16:45Z 3614 followers, XXX engagements


"I had Claude assemble a table for the AID programs I am tracking across many companies : $FATE $CRSP $CABA $ALLO $ACET"  
[X Link](https://x.com/JessieChimni/status/1989806239786918272)  2025-11-15T21:22Z 3615 followers, XXX engagements


"I like the over all progress being made by $VRTX/ $CRSP Casgevy. I am unsure if they will breakeven in 2028 (as stated by Sam) or 2029 but it should be close enough. A lot will depend on their patient enrollment over the next few years. They are progressing well with all the ATCs onboarded in 2025. They initiated XXX patients by end of Q3 which was 2x of what they in 2024. Some onboarding/initiation metrics are below: ATCs: Target to onboard XX ATCs achieved Start of 2025: Over XX ATCs globally May 2025: Over XX ATCs globally August 2025: Over XX ATCs globally. Through the end of Q3 2025 25"  
[X Link](https://x.com/JessieChimni/status/1988414115199807891)  2025-11-12T01:10Z 3612 followers, 4377 engagements


"@3primeAnalytica @GeneInvesting I wonder why they did not partner with $PRME instead 🤔. May be because of the litigation between $PRME & $BEAM regarding this indication"  
[X Link](https://x.com/JessieChimni/status/1995597582459179203)  2025-12-01T20:55Z 3613 followers, XXX engagements


"@wkissel @BiomedicalRX I agree. If you have longterm conviction let the winners run"  
[X Link](https://x.com/JessieChimni/status/1996797124126953488)  2025-12-05T04:21Z 3614 followers, XXX engagements